US Ambassador Calls on Health Minister – Discuss Pak-US collaboration in health sector

April 13, 2016

 Islamabad, the 13th April, 2016:- Ambassador of the United States to Pakistan David Hale called on Minister for National Health Services Saira Afzal Tarar here today, to discuss Pakistan – USA collaboration in the health sector. Secretary National Health Services Muhammad Ayub Shaikh and Director General Health Dr. Assad Hafeez were also present on the occasion. 

Minister expressed satisfaction over ongoing collaboration between the two countries in the area of disease control and prevention.

She said support of USAID has been vital in revamping Pakistan’s vaccine management system which is now of international standing and certified by ISO.

She said 83 districts of the country have the new VLMIS web based vaccine data management system which needs to be expanded to all districts of the country. To this end, the Minister sought support of the USAID.

She thanked the Ambassador for support in establishing a health dashboard in Islamabad where a centralized health database is available to inform planning and policy making.

The US Ambassador discussed with the Minister collaboration between Centres for Disease Control USA and Ministry of National Health Services Pakistan. Pak-US collaboration in implementing the Global Health Security Agenda was also discussed during the meeting.

Pakistan had taken major steps to control the epidemic of polio and was now well on track to stop poliovirus transmission, the Minister said. The Ambassador appreciated the strides taken in the effort by Pakistan.

The Minister informed the US Ambassador that Pakistan had a large pharmaceutical manufacturing sector with 600 indigenous manufactures.

She said the present government with the consensus of all stakeholders was successful in introducing Pakistan first-ever Drug Pricing Policy which has done away with discretion and established a fair system of price review based on commoner price index.

Special measures have been taken to enhance export of pharmaceuticals from the country with incentive to local companies who are exporting to countries with stringent drug regulatory regime.